Results about: peptide synthesis
The molecules synthesized by Ernest Giralt’s lab at IRB Barcelona bind a key protein in cancer that has received little attention as a therapeutic target.
The long-term goal is to provide a new chemotherapy treatment.
Ernest Giralt is to give a public conference at the Centre de Cultura Contemporània de Barcelona on Tuesday 29 September at 19h.
In front of a non-specialized audience, he will present the innovative research being done to overcome the blood-brain barrier and to provide drug treatments for neurological diseases.
Gate2Brain is one of the projects to receive research funding from the Obra Social “la Caixa”
The results of the IRB Barcelona project could have applications in various neurodegenerative diseases
Of the 221 projects presented, only 26 have been awarded funding